retatrutide clinical trial benefits The future of metabolic science is here, and it's called Retatrutide. 3 receptors, 1 goal. π #Biotech #weightloss #Retatrutide #peptides #wellness Eli Lilly's retatrutide shows promising
Description
Materials and methods Study design, participants, and procedures This was a randomized, double-blind, placebo-controlled study with a double-dummy, and crossover design
By causing more weight loss and lowering inflammation, blood sugar, cholesterol, and liver fat , these medicines can reduce risks for heart disease, diabetes, and fatty liver disease
Most GLP-1 medications are taken via injection daily or weekly
Phase 2 oral VK-2735 showed ~8.2% weight loss at 13 weeks competitive with early oral semaglutide data
Not everyone, however, was persuaded by Marks and Samols' results
Psychoneuroendocrinology 117, 104687
